ARDENA

Live / Registered — Registered — Section 71 accepted (as of 29 Jul 2024)

What this means for you

Registered since 19 Dec 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Dec 2027: the §71 ten-year affidavit of use).

Record

Serial number
79213596
Registration number
5357360
Mark type
Word mark
Filed
08 Mar 2017
Published for opposition
03 Oct 2017
Registered
19 Dec 2017
Next maintenance filing
§71 ten-year affidavit of use, due by 19 Dec 2027 (grace period to 19 Jun 2028)
Attorney of record
Clifford D. Hyra

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical research and pharmaceutical development; inspection of pharmaceutical products; research on pharmaceutical products; testing of pharmaceutical products; scientific investigations of pharmaceutical products for medical purposes; pharmaceutical development of drugs; development of pharmaceutical products; medical and pharmaceutical research services; consultancy pertaining to pharmacology; qualitative evaluation of pharmaceuticals; research relating to pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research regarding pharmaceutical products; research in the field of pharmacogenetics; scientific research in the field of pharmaceutics; testing of the effectiveness of pharmaceutical products; research and development services in the field of biology, gynecology, biotechnology, for others in the pharmaceutical industry; conducting clinical trials for others in the field of pharmaceutical products; research and development in the pharmaceutical field and biotechnology; consultancy relating to research and development in the pharmaceutical field; providing scientific research information in the field of clinical trials of pharmaceuticals; conducting early evaluations in the field of new pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research; [ providing scientific advice in relation to carbon offsetting; ] scientific testing; research and development services; conducting scientific feasibility studies; scientific analysis, namely, chemical analysis; [ scientific and technological services, namely, design in the field of computer networking hardware, computer datacenter architecture, ] scientific and technological services, namely, scientific research, analysis, testing, in the field of pharmaceuticals; providing scientific information in the field of biology, gynecology, biotechnology; providing of scientific research information in the field of, physics, genetics, pharmaceutical, biotechnology, gynecology; scientific medical research; scientific research for medical purposes; research in the field of physics, bacteriology, gynecology, biotechnology; contract research related to molecular sciences; research relating to molecular sciences; scientific research related to chemistry and biology; providing scientific research information in the field of genetics, physics, pharmaceuticals, biotechnology, organic chemistry
  • Class 045 — Legal and security services: Legal consultation and advice; reviewing standards and practices to assure compliance with pharmaceutical laws and regulations

Owner

Prosecution history

  • 24 Sept 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 05 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
  • 08 Jan 2026 — NEW REPRESENTATIVE AT IB RECEIVED
  • 26 Jul 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 30 Jun 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 30 Jun 2025 — INVALIDATION PROCESSED
  • 29 Mar 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 29 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 29 Jul 2024 — REGISTERED-SEC.71 ACCEPTED
  • 28 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 07 Nov 2023 — TEAS SECTION 71 RECEIVED
  • 19 Dec 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 12 May 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 27 Mar 2018 — FINAL DISPOSITION NOTICE SENT TO IB
  • 27 Mar 2018 — FINAL DISPOSITION PROCESSED

View this trademark record on Rightsy